PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients

肿瘤浸润性NK细胞和NKT细胞上PD-1以及其他免疫检查点的表达与未经治疗的CRC患者更长的无病生存期相关。

阅读:1

Abstract

A variety of variables, such as microsatellite instability or inflammatory mediators, are critical players in the development and progression of colorectal cancer (CRC). Natural killer (NK) and natural killer T (NKT) cells are involved in the prognoses of CRC. Immunological components of the tumor microenvironment (TME) impact cancer progression and therapeutic responses. We report that CRC patients with higher frequencies of tumor-infiltrating PD-1(+) NK and NKT cells had significantly longer disease-free survival (DFS) than patients with lower frequencies. In agreement with that, patients with higher frequencies of tumor-infiltrating PD-1(-) NK and NKT cells showed shorter DFS. There were no significant associations between tumor-infiltrating PD-1(+)TIM-3(+), PD-1(+)TIGIT(+), PD-1(+)ICOS(+), PD-1(+)LAG-3(+) NK cells, and PD-1(+)TIM-3(+), PD-1(+)TIGIT(+), and PD-1(+)LAG-3(+) NKT cells with DFS. This study highlights the significance of PD-1 expression on tumor-infiltrating NK and NKT cells and its association with disease prognoses in CRC patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。